Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.

Miskowiak KW, Vinberg M, Harmer CJ, Ehrenreich H, Knudsen GM, Macoveanu J, Hansen AR, Paulson OB, Siebner HR, Kessing LV.

Trials. 2010 Oct 13;11:97. doi: 10.1186/1745-6215-11-97.

2.

Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.

Miskowiak KW, Vinberg M, Christensen EM, Bukh JD, Harmer CJ, Ehrenreich H, Kessing LV.

Neuropsychopharmacology. 2014 May;39(6):1399-408. doi: 10.1038/npp.2013.335. Epub 2013 Dec 10.

3.

Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.

Miskowiak KW, Ehrenreich H, Christensen EM, Kessing LV, Vinberg M.

J Clin Psychiatry. 2014 Dec;75(12):1347-55. doi: 10.4088/JCP.13m08839.

PMID:
25099079
4.
5.

Neural correlates of improved executive function following erythropoietin treatment in mood disorders.

Miskowiak KW, Vinberg M, Glerup L, Paulson OB, Knudsen GM, Ehrenreich H, Harmer CJ, Kessing LV, Siebner HR, Macoveanu J.

Psychol Med. 2016 Jun;46(8):1679-91. doi: 10.1017/S0033291716000209. Epub 2016 Mar 21.

PMID:
26996196
6.

Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.

Vinberg M, Weikop P, Olsen NV, Kessing LV, Miskowiak K.

Brain Behav Immun. 2016 Oct;57:53-57. doi: 10.1016/j.bbi.2016.05.006. Epub 2016 May 12.

PMID:
27181179
7.

Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders.

Miskowiak KW, Vinberg M, Macoveanu J, Ehrenreich H, Køster N, Inkster B, Paulson OB, Kessing LV, Skimminge A, Siebner HR.

Biol Psychiatry. 2015 Aug 15;78(4):270-7. doi: 10.1016/j.biopsych.2014.12.013. Epub 2014 Dec 18.

PMID:
25641635
8.

Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.

Torrent C, Martinez-Arán A, Daban C, Amann B, Balanzá-Martínez V, del Mar Bonnín C, Cruz N, Franco C, Tabarés-Seisdedos R, Vieta E.

Compr Psychiatry. 2011 Nov-Dec;52(6):613-22. doi: 10.1016/j.comppsych.2010.12.009. Epub 2011 Feb 4.

PMID:
21295774
9.

The effect of erythropoietin on cognition in affective disorders - Associations with baseline deficits and change in subjective cognitive complaints.

Ott CV, Vinberg M, Kessing LV, Miskowiak KW.

Eur Neuropsychopharmacol. 2016 Aug;26(8):1264-73. doi: 10.1016/j.euroneuro.2016.05.009. Epub 2016 Jun 24.

PMID:
27349944
10.

Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales.

Luckenbaugh DA, Ameli R, Brutsche NE, Zarate CA Jr.

J Psychiatr Res. 2015 Feb;61:40-5. doi: 10.1016/j.jpsychires.2014.12.015. Epub 2014 Dec 27.

11.

Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.

Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN.

Neuropsychopharmacology. 2004 Aug;29(8):1538-45.

12.

Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.

Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ.

Psychopharmacology (Berl). 2009 Nov;207(1):133-42. doi: 10.1007/s00213-009-1641-1. Epub 2009 Aug 25.

PMID:
19705104
13.
14.

Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin.

Miskowiak KW, Rush AJ Jr, Gerds TA, Vinberg M, Kessing LV.

J Clin Psychiatry. 2016 Dec;77(12):e1639-e1646. doi: 10.4088/JCP.15m10480.

PMID:
27835716
15.

The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.

Vinberg M, Miskowiak K, Hoejman P, Pedersen M, Kessing LV.

PLoS One. 2015 May 26;10(5):e0127629. doi: 10.1371/journal.pone.0127629. eCollection 2015.

16.

Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study.

Xu G, Lin K, Rao D, Dang Y, Ouyang H, Guo Y, Ma J, Chen J.

J Affect Disord. 2012 Feb;136(3):328-39. doi: 10.1016/j.jad.2011.11.029. Epub 2011 Dec 12.

PMID:
22169253
17.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
18.

Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial.

Husain MI, Chaudhry IB, Rahman RR, Hamirani MM, Qurashi I, Khoso AB, Deakin JF, Husain N, Young AH.

Trials. 2015 Sep 15;16:410. doi: 10.1186/s13063-015-0933-5.

19.

Enhanced working and verbal memory after lamotrigine treatment in pediatric bipolar disorder.

Pavuluri MN, Passarotti AM, Mohammed T, Carbray JA, Sweeney JA.

Bipolar Disord. 2010 Mar;12(2):213-20. doi: 10.1111/j.1399-5618.2010.00792.x.

20.

Efficacy and cognitive side effects after brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy for major depression: a randomized, double-blind, controlled study.

Spaans HP, Verwijk E, Comijs HC, Kok RM, Sienaert P, Bouckaert F, Fannes K, Vandepoel K, Scherder EJ, Stek ML, Kho KH.

J Clin Psychiatry. 2013 Nov;74(11):e1029-36. doi: 10.4088/JCP.13m08538.

PMID:
24330903

Supplemental Content

Support Center